Solventum Co. (NYSE:SOLV) Given Average Rating of “Hold” by Analysts

Solventum Co. (NYSE:SOLV) has been given an average rating of “Hold” by the eleven research firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $68.29.

A number of equities analysts recently issued reports on the company. Stifel Nicolaus initiated coverage on Solventum in a report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price objective for the company. Wolfe Research assumed coverage on Solventum in a research note on Thursday, September 26th. They issued a “peer perform” rating for the company. Morgan Stanley lifted their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Piper Sandler increased their target price on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. Finally, Mizuho initiated coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price on the stock.

Institutional Trading of Solventum

A number of hedge funds and other institutional investors have recently made changes to their positions in SOLV. Worldquant Millennium Advisors LLC boosted its position in shares of Solventum by 373.6% in the 3rd quarter. Worldquant Millennium Advisors LLC now owns 47,665 shares of the company’s stock valued at $3,323,000 after purchasing an additional 37,600 shares during the period. Harbor Capital Advisors Inc. boosted its holdings in shares of Solventum by 24.8% in the fourth quarter. Harbor Capital Advisors Inc. now owns 46,965 shares of the company’s stock worth $3,103,000 after buying an additional 9,333 shares during the period. The Manufacturers Life Insurance Company increased its position in shares of Solventum by 37.4% in the third quarter. The Manufacturers Life Insurance Company now owns 117,853 shares of the company’s stock worth $8,217,000 after acquiring an additional 32,051 shares in the last quarter. State Street Corp raised its holdings in shares of Solventum by 3.1% during the third quarter. State Street Corp now owns 6,107,550 shares of the company’s stock valued at $425,818,000 after acquiring an additional 185,938 shares during the period. Finally, Point72 Asset Management L.P. purchased a new stake in shares of Solventum in the 3rd quarter valued at approximately $50,948,000.

Solventum Stock Performance

NYSE SOLV opened at $70.25 on Friday. The company has a 50-day moving average price of $69.18 and a two-hundred day moving average price of $65.24. Solventum has a 52 week low of $47.16 and a 52 week high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.